Interestingly, genome-wide association studies show the same variant is strongly associated with migraine, and Trpm8 modulators have been proposed to treat migraine (Dussor and Cao, 2016, Gormley et al., 2016). The gene discussed is TRPM8; the disease is migraine disorder.